New pill tested to slow scarring lung disease
NCT ID NCT05938920
Summary
This study tested a new oral medicine called INS018_055 in adults with idiopathic pulmonary fibrosis (IPF), a serious lung scarring disease. For 12 weeks, researchers compared the drug to a placebo pill in 71 participants to see if it was safe and if it could help slow the decline in lung function. The main goal was to check for side effects, while also measuring changes in how much air patients could forcefully breathe out.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS (IPF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anhui Chest Hospital
Hefei, Anhui, 230031, China
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, 100050, China
-
General Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, 300052, China
-
Hainan General Hospital
Haikou, Hainan, 570311, China
-
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, 330006, China
-
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, 510515, China
-
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, 210008, China
-
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100730, China
-
Peking University Shougang Hospital
Beijing, Beijing Municipality, 100041, China
-
Qilu Hospital of Shandong University
Jinan, Shandong, 250013, China
-
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, 200030, China
-
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, 201800, China
-
Shanxi Bethune Hospital
Taiyuan, Shanxi, 030032, China
-
The First Affiliated Hospital - Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310006, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052, China
-
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
-
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230601, China
-
The Second Xiangya Hospital of Central South University
Changsha, Hunan, 410011, China
-
The Shengjing Hospital of China medical university
Shenyang, Liaoning, 110004, China
-
The West China Hospital of Sichuan University
Chengdu, Sichuan, 610041, China
-
Xiangya Hospital of Central South University
Changsha, Hunan, 410008, China
-
Zhongshan hospital Fudan University
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.